EZETIMIBE/SIMVASTATINE ALTER 10 mg/40 mg, comprimé — plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 90 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930164310
  • CIP7 3016431
  • CIS 67065998

What the source publishes

Holder
LABORATOIRES ALTER
Active ingredients
SIMVASTATINE, ÉZÉTIMIBE
Form
comprimé
Package
plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 90 comprimé(s)
Routes
orale
Administrative status
cancelled
Supply regime
liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2018-10-24
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930164310
{
  "cis": "67065998",
  "cip7": "3016431",
  "form": "comprimé",
  "name": "EZETIMIBE/SIMVASTATINE ALTER 10 mg/40 mg, comprimé — plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 90 comprimé(s)",
  "cip13": "3400930164310",
  "holder": "LABORATOIRES ALTER",
  "routes": [
    "orale"
  ],
  "holders": [
    "LABORATOIRES ALTER"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": "40.18",
  "authorisedOn": "2018-10-24",
  "compositions": [
    {
      "name": "SIMVASTATINE",
      "nature": "SA",
      "strength": "40 mg",
      "linkageNumber": "2",
      "substanceCode": "10171",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "ÉZÉTIMIBE",
      "nature": "SA",
      "strength": "10 mg",
      "linkageNumber": "1",
      "substanceCode": "73242",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "2.76",
  "medicinePrice": "37.42",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "EZETIMIBE/SIMVASTATINE ALTER 10 mg/40 mg, comprimé",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-17",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 90 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2024-12-31",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "cancelled",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "SIMVASTATINE",
    "ÉZÉTIMIBE"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation abrogée",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930164310"